Strength of relationships of the pulse wave velocity and central hemodynamic indices with the serum N-terminal fragment B-type natriuretic peptide levels in men - A worksite cohort study -

Circulation Journal

Volumn 76, Issue 8, 2012, Pages 1928-1933

  Odaira, Mari ^a   Tomiyama, Hirofumi ^a   Matsumoto, Chisa ^a   Yoshida, Masanobu ^a   Shiina, Kazuki ^a   Nagata, Mikio ^b   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KAJIMA CORPORATION   (Japan)

Author keywords

Central hemodynamics; Left ventricular afterload; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HUMAN; IMMUNOASSAY; MALE; OSCILLOMETRY; PLETHYSMOGRAPHY; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84864381154     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0044     Document Type: Article

References (33)

1. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, et al. B-type natriuretic peptides and cardiovascular risk: Systematic review and meta-analysis of 40 prospective studies. Circulation 2009; 120: 2177-2187.
2. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and metaanalysis. Eur Heart J 2010; 31: 1865-1871.
3. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: A clinical perspective. J Am Coll Cardiol 2007; 50: 1-13.
4. Tomiyama H, Yamashina A. Non-invasive vascular function tests: Their pathophysiological background and clinical application. Circ J 2010; 74: 24-33.
5. Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 2005; 18: 3S-10S.
6. Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation 2011; 123: 551-565.
7. Maeder MT, Mariani JA, Kaye DM. Hemodynamic determinants of myocardial B-type natriuretic peptide release: Relative contributions of systolic and diastolic wall stress. Hypertension 2010; 56: 682-689.
8. Chirinos JA, Segers P. Noninvasive evaluation of left ventricular afterload: Part 1: Pressure and flow measurements and basic principles of wave conduction and reflection. Hypertension 2010; 56: 555-562.
9. Chirinos JA, Segers P. Noninvasive evaluation of left ventricular afterload: Part 2: Arterial pressure-flow and pressure-volume relations in humans. Hypertension 2010; 56: 563-570.
10. Yambe M, Tomiyama H, Koji Y, Motobe K, Shiina K, Gulnisia Z, et al. B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens 2006; 19: 443-447.
11. Rutten JHW, Mattace-Raso FUS, Verwoert GC, Lindmans J, Hofman A, Witteman JCM, et al. Arterial stiffness as a determinant of increased amino terminal pro-B-type natriuretic peptide levels in individuals with and without cardiovascular disease: Rotterdam Study. J Hypertens 2010; 28: 2061-2067.
12. Kaji Y, Miyoshi T, Doi M, Hirohata S, Kamikawa S, Sakane K, et al. Augmentation index is associated with B-type natriuretic peptide in patients with paroxysmal atrial fibrillation. Hypertens Res 2009; 32: 611-616.
13. Levy D, Hwang SJ, Kayalar A, Benjamin EJ, Vasan RS, Parise H, et al. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: The Framingham Heart Study. Circulation 2007; 115: 3079-3085.
14. Jankowski P, Kawecka-Jaszcz K, Czarnecka D, Brzozowska-Kiszka M, Styczkiewicz K, Loster M, et al. Aortic Blood Pressure and Survival Study Group. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension 2008; 51: 848-855.
15. Melenovsky V, Borlaug BA, Fetics B, Kessler K, Shively L, Kass DA. Estimation of central pressure augmentation using automated radial artery tonometry. J Hypertens 2007; 25: 1403-1409.
16. Tomiyama H, Yamazaki M, Sagawa Y, Teraoka K, Shirota T, Miyawaki Y, et al. Synergistic effect of smoking and blood pressure on augmentation index in men, but not in women. Hypertens Res 2009; 32: 122-126.
17. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213-1225.
18. Odaira M, Tomiyama H, Matsumoto C, Yamada J, Yoshida M, Shiina K, et al. Association of serum cystatin C with pulse wave velocity, but not pressure wave reflection, in subjects with normal renal function or mild chronic kidney disease. Am J Hypertens 2010; 23: 967-973.
19. Tomiyama H, Hashimoto H, Tanaka H, Matsumoto C, Odaira M, Yamada J, et al. Continuous smoking and progression of arterial stiffening: A prospective study. J Am Coll Cardiol 2010; 55: 1979-1987.
20. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007; 50: 927-937.
21. Temmar M, Jankowski P, Peltier M, Mouquet V, Debicka-Dabrowska D, Hamida F, et al. Intraaortic pulse pressure amplification in subjects at high coronary risk. Hypertension 2010; 55: 327-332.
22. Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: The Strong Heart Study. J Hypertens 2010; 28: 384-388.
23. Mitchell GF, Lacourcière Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: The role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation 2003; 108: 1592-1598.
24. Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, et al. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: The Hisayama study. Arterioscler Thromb Vasc Biol 2011; 31: 2997-3003.
25. Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK, et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol 2005; 96: 1284-1289.
26. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 2007; 50: 197-203.
27. Casals G, Ros J, Sionis A, Davidson MM, Morales-Ruiz M, Jiménez W. Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes. Am J Physiol Heart Circ Physiol 2009; 297: H550-H555.
28. Nichols WW, Denardo SJ, Wilkinson IB, McEniery CM, Cockcroft J, O'Rourke MF. Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens (Greenwich) 2008; 10: 295-303.
29. Safar ME. Arterial aging--hemodynamic changes and therapeutic options. Nat Rev Cardiol 2010; 7: 442-449.
30. Turin TC, Kita Y, Rumana N, Takashima N, Kadota A, Matsui K, et al. Brachial-ankle pulse wave velocity predicts all-cause mortality in the general population: Findings from the Takashima study, Japan. Hypertens Res 2010; 33: 922-925.
31. Igarashi Y, Chikamori T, Hida S, Tanaka H, Shiba C, Usui Y, et al. Importance of the ankle-brachial pressure index in the diagnosis of coronary artery disease in women with diabetes without anginal pain. Circ J 2011; 75: 2206-2212.
32. Hongo M, Kumazaki S, Izawa A, Hidaka H, Tomita T, Yazaki Y, et al. Low-dose rosuvastatin improves arterial stiffness in high-risk Japanese patients with dyslipdemia in a primary prevention group. Circ J 2011; 75: 2660-2667.
33. Wohlfahrt P, Wichterle D, Seidlerová J, Filipovský J, Bruthans J, Adámková V, et al. Relation of central and brachial blood pressure to left ventricular hypertrophy: The Czech Post-MONICA Study. J Hum Hypertens 2012; 26: 14-19.